Expert insights on what to expect, how to prepare, and how
to support your recovery—covering diagnosis, treatment, and
beyond.
My mother was diagnosed with breast cancer stage IV, she is in her 70s and has heart disease, the local hospital is afraid to do surgery, is there any effective treatment?
Combined knife ablation is ultra-fine cold and hot composite ablation, usually within 20-25 minutes of rapid tumor coagulation necrosis, and apoptosis, suitable for advanced elderly patients.
What are the treatment options for recurrent lymphoma?
Diffuse large B cell lymphoma, the effect of this treatment with CAR-T is very good except that it’s expensive. If the your economic condition is good, you can consider using CAR-T treatment, there is hope that you can be ‘cured’!
Esophageal cancer stage IV is poorly treated in local hospitals, is there any other options without removing?
There are many treatments for esophageal cancer, but it’s necessary to confirm whether there are problems such as metastasis. At present, interventional therapy or seed implantation will be more suitable, less painful, and safer.
Get a Free Consultation
Our specialists are ready to review your case and design a personalised treatment plan.
We break through traditional one-oncologist models. Our MDT approach brings together
experts from radiology, surgery, TCM, and internal medicine to formulate your
personalized plan.
Our patient coordinators are available 24/7 to review your diagnosis, explain which technologies apply, and arrange a free multidisciplinary case review.
Prof. Song Shijun is a professor, chief physician, and CPC member with over 40 years of clinical experience in oncology. He specializes in chemotherapy, minimally invasive therapy, biotherapy, and targeted therapy for various solid tumors.
Medical Experience
Over 40 years of clinical oncology experience.
Chief Expert of the Oncology Department and leader of the Multidisciplinary Team (MDT).
Specialized in chemotherapy, minimally invasive therapy, targeted therapy, biotherapy, and integrated cancer treatment.
Extensive experience in treating complex and advanced-stage malignant tumors.
Pioneer in integrating minimally invasive treatment with immunotherapy and precision medicine.
Has successfully treated more than 10,000 cancer patients, with many achieving long-term survival exceeding 10 years.
Frequently participates in international oncology conferences and promotes medical collaboration across Southeast Asia.
Research Areas
Precision Oncology
Minimally Invasive Cancer Therapy
Targeted Therapy
Biotherapy and Immunotherapy
Multidisciplinary Team (MDT) Cancer Management
Radiofrequency Ablation (RFA)
Palliative Care for Advanced Cancer
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Molecular Biomarkers in Cancer
Personalized Cancer Treatment Strategies
Book Consultation
Prof. Dai Wenyan
Director of Oncology Department · Director of Breast Cancer Center
Chief Physician
Introduction
Dr. Ma Xiaoying is a renowned oncologist with over 20 years of clinical experience. Specializing in precision minimally invasive therapy, she has treated more than 5,000 international patients, focusing on improving the quality of life and survival rates for advanced-stage cancer patients.
Medical Experience
Over 20 years of clinical work in oncology and cancer research.
Expertise in multidisciplinary (MDT) consultation and personalized treatment planning.
Completed advanced studies at the National University of Singapore (2015) and Sun Yat-sen University Cancer Center (2017 & 2019).
Specialist in minimally invasive techniques including interventional therapy, seed implantation, and cryotherapy.
Research Areas
Precision minimally invasive cancer treatment technologies.
Combination of targeted therapy, immunotherapy, and chemotherapy for refractory tumors.
Endoscopic diagnosis and treatment of malignant tumors.
Integrated medical models for advanced-stage cancer management.
Book Consultation
Ma Xiaoying
Director of Oncology Department
Associate Chief Physician
Introduction
Dr. Ma Xiaoying is a renowned oncologist with over 20 years of clinical experience. She specializes in minimally invasive precision treatments, combining targeted therapy and immunotherapy to provide individualized plans for advanced cancer patients, focusing on improving their quality of life.
Medical Experience
More than 20 years of extensive clinical work in the field of oncology.
Expertise in treating advanced and refractory tumors with rich clinical results.
Successfully treated over 5,000 international patients, particularly from Southeast Asia.
Proficient in implementing multidisciplinary (MDT) treatment plans and managing cancer complications.
Research Areas
Integration of minimally invasive technologies (interventional therapy, cryotherapy, microwave ablation) with molecular targeted therapy.
Individualized and comprehensive treatment protocols for solid tumors.
Advanced techniques in tumor endoscopy for both diagnosis and treatment.
Research on biological immunotherapy and endocrine therapy for late-stage cancers.
Book Consultation
Dr. Wang Baoli
Oncology Specialist
Associate Chief Physician
Introduction
Nearly 20 years of clinical oncology experience in China's top-tier Grade A tertiary hospitals. Expert in minimally invasive interventional therapy, chemotherapy, and combined targeted-immunotherapy, focusing on complex cancers and advocating a Multidisciplinary Team (MDT) treatment approach.
Medical Experience
Member, Hepatobiliary and Pancreatic Tumors Professional Committee, Guangzhou Anti-Cancer Association
Member, Tumor Immunotherapy Professional Committee, Guangdong Pharmaceutical Association
Member, Interventional Medicine Professional Committee, Guangzhou Medical Association
Member, Liver Cancer Professional Committee, Tumor Rehabilitation Branch, Chinese Geriatrics Society
Member, Thyroid Nodule and Tumor Prevention and Control Professional Committee, China Health Care Association
Published 5 papers in core medical journals and 1 SCI-indexed paper
Awarded 1 Third Prize for Military Medical Achievements
Participated in 1 provincial-level government-funded research project
Research Areas
Integrated minimally invasive therapy for tumors
Multidisciplinary Team (MDT) precision personalized diagnosis and treatment model
Application of combined targeted and immunotherapy strategies in oncology